SINOVAC BIOTECH LTD
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $25.8M | $-596.0K | $-1.4M | $-1.5M | $7.4M | $-18.7M | $-844.7K | $-8.5M |
| Depreciation & Amortization | — | — | — | — | — | $4.5M | $4.8M | $4.2M |
| Depreciation | $4.6M | $5.1M | $6.3M | $7.8M | $5.7M | $4.0M | $4.3M | $3.7M |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $979.0K | $2.4M | $952.0K | $287.0K | $281.0K | $347.0K | $206.0K | $459.9K |
| Net Cash from Operating Activities | $59.8M | $-13.9M | $4.2M | $-10.1M | $5.6M | $-16.3M | $13.9M | $-14.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $11.9M | $12.7M | $5.3M | $10.9M | $5.1M | $16.2M | $15.5M | $24.8M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-11.9M | $-11.8M | $-4.5M | $-11.0M | $-5.2M | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | $802.2K | $5.9M | $3.3M |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-1.3M | $27.8M | $-24.2M | $5.3M | $14.4M | — | — | — |
| Net Change in Cash | $52.0M | $-1.5M | $-26.0M | $-17.2M | $15.3M | $-13.0M | $2.7M | $26.6M |
| Free Cash Flow | $47.8M | $-26.6M | $-1.1M | $-21.0M | $443.0K | $-32.4M | $-1.5M | $-39.1M |